International Journal of Advances In Case Reports

SURGICAL SITE INFECTIONS AFTER LAPAROSCOPIC SLEEVE GASTRECTOMY, A CASE SERIES

Haitham Mohammad Al Falah, Saleh M. Al Salamah*, Muhammad Izaz Hashmi, Manayer Saleh Al Salamah, Jovial De Souza, Ghanem Suliman Abbas

smsalamah@hotmail.com

Laparoscopic sleeve gastrectomy, Surgical site infection, Obesity, Bariatric surgery.

The surgical wound encompasses the area of the body, both internally and externally, that involves the entire operative site. For discussion and classification purpose a surgical wound can be divided into three anatomical levels depending upon its depth, which are: 1. Superficial: the skin and subcutaneous tissue 2. Deep: the fascia and muscle 3. Organ-space: internal organs and or body cavities. Three patients had surgical site infections and we wanted to evaluate whether any modification in our method needed to be done. Two patients out of 217 had SSI but the aetiology was due to staple line leak for one case and mesenteric ischemia for the other. These cases were thus excluded from the study. Laparoscopic sleeve gastrectomy (LSG) is one of the most commonly performed and popular procedure for weight loss in the morbidly obese patient and the weight loss seen both in short and intermediate-term is encouraging. LSG is classified as a clean contaminated surgery and carries its own risk of surgical site infection. The aim of this study is to evaluate the incidences of surgical site infections (SSI) after LSG. Two hundred and seventeen patients who underwent LSG were reviewed retrospectively. Data analysis was conducted serially during follow up of these patients to look for complications. Three patients had SSI which were a spectrum of superficial surgical site infections (wound infections), space infections (peritonitis) and organ infection (liver abscess). Each of these patients underwent intervention to treat that infection and all of them improved afterward. The incidence of SSI were <2% which is in the accepted international range of SSI for clean contaminated surgeries proposed as 4% and up to 6 to 9%. LSG is a modern choice for treatment of morbid obesity with low SSI rates. [10]